Boston Scientific BSX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $20.62B+17.4% | $20.08B+19.9% | $19.35B+21.6% | $18.49B+21.4% | $17.55B+19.4% | ||
| $6.36B+15.6% | $6.22B+18.3% | $6.08B+23.1% | $5.87B+24.1% | $5.5B+21.8% | ||
| $14.26B+18.3% | $13.85B+20.6% | $13.27B+21.0% | $12.63B+20.2% | $12.05B+18.2% | ||
| 69.2%+0.5pp | 69%+0.4pp | 68.6%-0.4pp | 68.3%-0.7pp | 68.7%-0.6pp | ||
| $7.07B+13.8% | $6.89B+15.1% | $6.67B+15.9% | $6.49B+19.4% | $6.22B+16.4% | ||
| $10.47B+13.7% | $10.24B+15.2% | $9.81B+15.9% | $9.48B+18.0% | $9.2B+19.1% | ||
| $3.79B+33.1% | $3.61B+38.8% | $3.46B+37.9% | $3.15B+27.3% | $2.85B+15.5% | ||
| 18.4%+2.2pp | 18%+2.5pp | 17.9%+2.1pp | 17%+0.8pp | 16.2%-0.5pp | ||
| $357M+12.3% | $349M+14.4% | $339M+16.9% | $331M+19.5% | $318M+17.8% | ||
| $3.74B+50.9% | $3.39B+48.3% | $3.27B+48.5% | $3B+40.0% | $2.48B+15.4% | ||
| $183M-59.7% | $492M+12.8% | $485M+17.1% | $502M+57.4% | $454M+20.4% | ||
| $3.56B+75.8% | $2.89B+56.7% | $2.78B+55.8% | $2.5B+37.0% | $2.02B+14.3% | ||
| 17.3%+5.7pp | 14.4%+3.4pp | 14.4%+3.2pp | 13.5%+1.5pp | 11.5%-0.5pp | ||
| $2.39+74.5% | $1.94+55.2% | $1.87+54.5% | $1.68+36.6% | $1.37+15.1% | ||
| $5.19B+25.3% | $4.98B+28.6% | $4.81B+28.5% | $4.46B+20.6% | $4.14B+12.4% | ||
| 25.2%+1.6pp | 24.8%+1.7pp | 24.9%+1.3pp | 24.1%-0.2pp | 23.6%-1.4pp | ||
| $3.79B+33.1% | $3.61B+38.8% | $3.46B+37.9% | $3.15B+27.3% | $2.85B+15.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Boston Scientific's revenue?
- Boston Scientific (BSX) generated $20.6B in revenue over the trailing twelve months, up 17.4% year over year.
- Is Boston Scientific profitable?
- Boston Scientific reported $3.6B in net income over the trailing twelve months, a 17.3% net margin.
- What are Boston Scientific's profit margins?
- Gross margin is 69.2% and operating margin is 18.4%, with a 17.3% net margin.
- What is Boston Scientific's earnings per share?
- Boston Scientific's diluted EPS over the trailing twelve months is $2.39.
- Where does Boston Scientific's income statement data come from?
- Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
